Aramark Form 8-K Summary: Executive Leadership Transition
Business Context and Reporting Period
This Current Report on Form 8-K, dated January 4, 2020, reports a significant change in executive leadership at Aramark. The filing details the departure of the Chief Financial Officer (CFO) and the appointment of a successor, effective January 7, 2020.
Key Financial Metrics and Compensation
The filing does not report operational financial metrics such as revenue, profit, cash flow, or debt levels. Instead, it discloses specific compensation figures related to the executive transition:
- Outgoing CFO (Stephen Bramlage) Separation Package:
- Base salary continuation: 18 months ($1,166,925).
- 2019 Target Bonus: 1.5x target ($1,166,925).
- 2020 Prorated Bonus: Estimated at $388,975.
- Automobile Allowance: 18 months ($19,800).
- Outplacement Counseling: Up to $155,590.
- Medical Insurance: 18 months of company-paid coverage.
- Incoming CFO (Thomas Ondrof) Compensation:
- Base Salary: $800,000 annually.
- Target Bonus: 100% of base salary.
- Equity Awards (Grant Date Fair Value):
- $600,000 in non-qualified stock options (4-year vest).
- $400,000 in time-based restricted stock units (4-year vest).
- $1,000,000 in performance stock units (3-year cliff vest).
- Car Allowance: $1,100 monthly.
Material Changes
The primary material change is the replacement of Stephen Bramlage as Executive Vice President, Chief Financial Officer, principal financial officer, and principal accounting officer. Mr. Bramlage steps down effective January 6, 2020, and will serve as an Executive Advisor until April 3, 2020. Thomas Ondrof assumes the CFO role effective January 7, 2020.
Outlook, Risks, and Contingencies
The filing outlines specific contingencies regarding the new CFO's employment agreement:
- Termination Provisions: Mr. Ondrof is entitled to 18 months of base salary continuation if terminated without "Cause." In the event of a "Change of Control" followed by termination without Cause or resignation for "Good Reason," he is entitled to 2.0x base salary and 2.0x target bonus, plus pro-rated bonuses and medical benefits.
- Non-Compete Covenants: Both executives are subject to post-employment non-competition, non-solicitation, and non-hire covenants. Mr. Bramlage's non-compete lasts 18 months; Mr. Ondrof's lasts 24 months (reduced to 18 months if terminated without Cause).
- Release of Claims: Mr. Bramlage must execute a release of claims to receive cash payments under his separation agreement.
Investor Verification Checklist
- Verify the exact effective dates of the CFO transition (Jan 6 vs. Jan 7, 2020) for accounting period attribution.
- Review the total cash outflow for Mr. Bramlage's separation package ($2.74M+ in cash/benefits) and its impact on Q1 2020 expenses.
- Confirm the vesting schedule and performance metrics for Mr. Ondrof's $2.2M equity grant.
- Assess the potential liability for Mr. Ondrof's change-of-control severance (2.0x salary and bonus) in the context of M&A activity.
- Check for any subsequent filings regarding the performance metrics established for Mr. Ondrof's performance stock units.